Seiko Otokozawa

3.4k total citations
28 papers, 1.4k citations indexed

About

Seiko Otokozawa is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cancer Research. According to data from OpenAlex, Seiko Otokozawa has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Surgery and 12 papers in Cancer Research. Recurrent topics in Seiko Otokozawa's work include Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Lipoproteins and Cardiovascular Health (11 papers) and Cancer, Lipids, and Metabolism (10 papers). Seiko Otokozawa is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Lipoproteins and Cardiovascular Health (11 papers) and Cancer, Lipids, and Metabolism (10 papers). Seiko Otokozawa collaborates with scholars based in United States, Japan and Netherlands. Seiko Otokozawa's co-authors include Ernst J. Schaefer, Masumi Ai, Bela F. Asztalos, Katsuyuki Nakajima, Naoki Watanabe, Nobuyuki Uehara, Atsuhito Yagihashi, Naoki Tsuji, Kei Kondo and Daisuke Kobayashi and has published in prestigious journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Seiko Otokozawa

28 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Seiko Otokozawa United States	20	585	552	296	271	243	28	1.4k
M.P.C. Hectors Netherlands	14	349 0.6×	479 0.9×	239 0.8×	207 0.8×	87 0.4×	35	1.3k
Toshimitsu Ito Japan	20	264 0.5×	481 0.9×	476 1.6×	181 0.7×	120 0.5×	49	1.9k
Mehran Haidari United States	19	248 0.4×	175 0.3×	395 1.3×	344 1.3×	107 0.4×	31	1.4k
Darbie Maccubbin United States	23	400 0.7×	685 1.2×	200 0.7×	111 0.4×	213 0.9×	62	1.5k
Bin Zhao China	23	151 0.3×	400 0.7×	388 1.3×	154 0.6×	175 0.7×	97	1.5k
Scott Lucia United States	12	278 0.5×	387 0.7×	449 1.5×	147 0.5×	93 0.4×	21	1.5k
Mark Walsh Canada	20	282 0.5×	758 1.4×	421 1.4×	364 1.3×	98 0.4×	39	2.2k
Henri O.F. Molhuizen Netherlands	13	248 0.4×	961 1.7×	565 1.9×	112 0.4×	147 0.6×	17	1.6k
Ingibjörg Harðardóttir Iceland	22	188 0.3×	388 0.7×	501 1.7×	278 1.0×	125 0.5×	55	1.7k
Qiaozhu Su United States	23	543 0.9×	265 0.5×	738 2.5×	876 3.2×	249 1.0×	50	1.9k

Countries citing papers authored by Seiko Otokozawa

Since Specialization

Citations

This map shows the geographic impact of Seiko Otokozawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiko Otokozawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiko Otokozawa more than expected).

Fields of papers citing papers by Seiko Otokozawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seiko Otokozawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiko Otokozawa. The network helps show where Seiko Otokozawa may publish in the future.

Co-authorship network of co-authors of Seiko Otokozawa

This figure shows the co-authorship network connecting the top 25 collaborators of Seiko Otokozawa. A scholar is included among the top collaborators of Seiko Otokozawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seiko Otokozawa. Seiko Otokozawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ikezaki, Hiroaki, Masumi Ai, Ernst J. Schaefer, et al.. (2017). Cardiovascular disease prevalence and insulin resistance in the Kyushu–Okinawa Population Study and the Framingham Offspring Study. Journal of clinical lipidology. 11(2). 348–356. 13 indexed citations

Minatoya, Machiko, Goro Kutomi, Hiroaki Shima, et al.. (2014). Relation of Serum Adiponectin Levels and Obesity with Breast Cancer: A Japanese Case-Control Study. Asian Pacific Journal of Cancer Prevention. 15(19). 8325–8330. 17 indexed citations

Minatoya, Machiko, Goro Kutomi, Seiko Otokozawa, et al.. (2013). Relationship of serum isoflavone, insulin and adiponectin levels with breast cancer risk. Breast Cancer. 22(5). 452–461. 13 indexed citations

Minatoya, Machiko, Goro Kutomi, Seiko Otokozawa, et al.. (2013). Equol, Adiponectin, Insulin Levels and Risk of Breast Cancer. Asian Pacific Journal of Cancer Prevention. 14(4). 2191–2199. 28 indexed citations

Brouwers, Martijn C.G.J., Robert J. Konrad, Thomas M. van Himbergen, et al.. (2013). Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemia. Nutrition Metabolism and Cardiovascular Diseases. 23(11). 1115–1121. 17 indexed citations

Furusyo, Norihiro, Masumi Ai, Seiko Otokozawa, et al.. (2012). Plasma glycated albumin level and atherosclerosis: Results from the Kyushu and Okinawa Population Study (KOPS). International Journal of Cardiology. 167(5). 2066–2072. 53 indexed citations

Ai, Masumi, Seiko Otokozawa, Bela F. Asztalos, et al.. (2011). Adiponectin: An independent risk factor for coronary heart disease in men in the Framingham offspring Study. Atherosclerosis. 217(2). 543–548. 74 indexed citations

Thongtang, Nuntakorn, Masumi Ai, Seiko Otokozawa, et al.. (2011). Effects of Maximal Atorvastatin and Rosuvastatin Treatment on Markers of Glucose Homeostasis and Inflammation. The American Journal of Cardiology. 107(3). 387–392. 62 indexed citations

Furusyo, Norihiro, Toshiki Koga, Seiko Otokozawa, et al.. (2011). Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS). Diabetologia. 54(12). 3028–3036. 120 indexed citations

10.

Otokozawa, Seiko, Masumi Ai, Bela F. Asztalos, et al.. (2010). Direct assessment of plasma low density lipoprotein and high density lipoprotein cholesterol levels and coronary heart disease: Results from the Framingham Offspring Study. Atherosclerosis. 213(1). 251–255. 26 indexed citations

11.

Nakajima, Katsuyuki, Jun Kobayashi, Hiroshi Mabuchi, et al.. (2010). Association of angiopoietin-like protein 3 with hepatic triglyceride lipase and lipoprotein lipase activities in human plasma. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 47(5). 423–431. 37 indexed citations

12.

Himbergen, Thomas M. van, Seiko Otokozawa, Nirupa R. Matthan, et al.. (2009). Familial Combined Hyperlipidemia Is Associated With Alterations in the Cholesterol Synthesis Pathway. Arteriosclerosis Thrombosis and Vascular Biology. 30(1). 113–120. 35 indexed citations

13.

Vega‐López, Sonia, Nirupa R. Matthan, Lynne M. Ausman, et al.. (2009). Altering dietary lysine:arginine ratio has little effect on cardiovascular risk factors and vascular reactivity in moderately hypercholesterolemic adults. Atherosclerosis. 210(2). 555–562. 23 indexed citations

14.

Otokozawa, Seiko, Masumi Ai, Margaret R. Diffenderfer, et al.. (2009). Fasting and postprandial apolipoprotein B-48 levels in healthy, obese, and hyperlipidemic subjects. Metabolism. 58(11). 1536–1542. 46 indexed citations

15.

Ai, Masumi, Seiko Otokozawa, Ernst J. Schaefer, et al.. (2009). Glycated albumin and direct low density lipoprotein cholesterol levels in type 2 diabetes mellitus. Clinica Chimica Acta. 406(1-2). 71–74. 22 indexed citations

16.

Lamon‐Fava, Stefania, Margaret R. Diffenderfer, P. Hugh R. Barrett, et al.. (2008). Extended-Release Niacin Alters the Metabolism of Plasma Apolipoprotein (Apo) A-I and ApoB-Containing Lipoproteins. Arteriosclerosis Thrombosis and Vascular Biology. 28(9). 1672–1678. 116 indexed citations

17.

Kobayashi, Nobumichi, Shigeo Nagashima, Masaho Ishino, et al.. (2008). Diversity of staphylocoagulase and identification of novel variants of staphylocoagulase gene in Staphylococcus aureus. Microbiology and Immunology. 52(7). 334–348. 21 indexed citations

18.

Otokozawa, Seiko, Masumi Ai, Thomas M. van Himbergen, et al.. (2008). Effects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levels. Atherosclerosis. 205(1). 197–201. 29 indexed citations

19.

Himbergen, Thomas M. van, Nirupa R. Matthan, Nancy Resteghini, et al.. (2008). Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers. Journal of Lipid Research. 50(4). 730–739. 81 indexed citations

20.

Ai, Masumi, Seiko Otokozawa, Bela F. Asztalos, et al.. (2007). Effects of Maximal Doses of Atorvastatin Versus Rosuvastatin on Small Dense Low-Density Lipoprotein Cholesterol Levels. The American Journal of Cardiology. 101(3). 315–318. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact